Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease

por Hoermann, Gregor
Publicado 2022

Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms

por Hoermann, Gregor, Greiner, Georg, Valent, Peter
Publicado 2015

Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology

por Hoermann, Gregor, Greiner, Georg, Griesmacher, Andrea, Valent, Peter
Publicado 2020

The Microtubule-Associated Protein Tau and Its Relevance for Pancreatic Beta Cells

por Maj, Magdalena, Hoermann, Gregor, Rasul, Sazan, Base, Wolfgang, Wagner, Ludwig, Attems, Johannes
Publicado 2016

Lipoprotein(a) is not related to markers of insulin resistance in pregnancy

por Todoric, Jelena, Handisurya, Ammon, Leitner, Karoline, Harreiter, Juergen, Hoermann, Gregor, Kautzky-Willer, Alexandra
Publicado 2013

P689: CLASSIFICATION OF MDS AND AML BASED SOLELY ON GENETICS OMITTING BLAST COUNTING – A WAY TO RESOLVE THE DISCREPANCIES BETWEEN CLASSIFICATIONS ACCORDING TO WHO AND ICC?

por Haferlach, Claudia, Huber, Sandra, Baer, Constance, Hutter, Stephan, Meggendorfer, Manja, Kern, Wolfgang, Haferlach, Torsten, Hoermann, Gregor
Publicado 2023

Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survival

por Geissler, Klaus, Jäger, Eva, Barna, Agnes, Graf, Temeida, Graf, Elmir, Öhler, Leopold, Hoermann, Gregor, Valent, Peter
Publicado 2021

SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosis

por Huber, Sandra, Haferlach, Torsten, Meggendorfer, Manja, Hutter, Stephan, Hoermann, Gregor, Baer, Constance, Kern, Wolfgang, Haferlach, Claudia
Publicado 2022

SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phase

por Huber, Sandra, Haferlach, Torsten, Meggendorfer, Manja, Hutter, Stephan, Hoermann, Gregor, Baer, Constance, Kern, Wolfgang, Haferlach, Claudia
Publicado 2022

Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond

por Sprinzl, Bettina, Greiner, Georg, Uyanik, Goekhan, Arock, Michel, Haferlach, Torsten, Sperr, Wolfgang R., Valent, Peter, Hoermann, Gregor
Publicado 2021

MDS subclassification—do we still have to count blasts?

por Huber, Sandra, Haferlach, Torsten, Müller, Heiko, Meggendorfer, Manja, Hutter, Stephan, Hoermann, Gregor, Baer, Constance, Kern, Wolfgang, Haferlach, Claudia
Publicado 2023

Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors

por Byrgazov, Konstantin, Lucini, Chantal Blanche, Berkowitsch, Bettina, Koenig, Margit, Haas, Oskar A., Hoermann, Gregor, Valent, Peter, Lion, Thomas
Publicado 2016

Cardio-pathogenic variants in unexplained intrauterine fetal death: a retrospective pilot study

por Muin, Dana A., Kollmann, Martina, Blatterer, Jasmin, Hoermann, Gregor, Husslein, Peter W., Lafer, Ingrid, Petek, Erwin, Schwarzbraun, Thomas
Publicado 2021

AML classification in the year 2023: How to avoid a Babylonian confusion of languages

por Huber, Sandra, Baer, Constance, Hutter, Stephan, Dicker, Frank, Meggendorfer, Manja, Pohlkamp, Christian, Kern, Wolfgang, Haferlach, Torsten, Haferlach, Claudia, Hoermann, Gregor
Publicado 2023

P694: RISK ASSESSMENT ACCORDING TO IPSS-M IS SUPERIOR TO AML ELN 2022 RISK CLASSIFICATION IN MDS/AML PATIENTS DEFINED BY ICC – IS AN INCLUSION INTO AML TRIALS JUSTIFIED?

por Huber, Sandra, Baer, Constance, Hutter, Stephan, Dicker, Frank, Meggendorfer, Manja, Pohlkamp, Christian, Kern, Wolfgang, Haferlach, Torsten, Haferlach, Claudia, Hoermann, Gregor
Publicado 2023

Cytomegalovirus in urinary sediment in patients with acute kidney injury

por Pajenda, Sahra, Kapps, Sebastian, Gerges, Daniela, Hoermann, Gregor, Wagner, Ludwig, Buchtele, Nina, Geist, Barbara, Strassl, Robert, Schmidt, Alice, Winnicki, Wolfgang
Publicado 2021

Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts

por Huber, Sandra, Haferlach, Torsten, Meggendorfer, Manja, Hutter, Stephan, Hoermann, Gregor, Summerer, Isolde, Fuhrmann, Irene, Baer, Constance, Kern, Wolfgang, Haferlach, Claudia
Publicado 2022

P708: HIGH MUTATIONAL CONCORDANCE IN PAIRED BONE MARROW AND PERIPHERAL BLOOD SAMPLES IN PATIENTS WITH CONFIRMED OR SUSPECTED MYELODYSPLASTIC NEOPLASM

por Wossidlo, Natalie, Huber, Sandra, Haferlach, Torsten, Meggendorfer, Manja, Hutter, Stephan, Hoermann, Gregor, Summerer, Isolde, Ruge, Henning, Baer, Constance, Kern, Wolfgang, Haferlach, Claudia
Publicado 2023

Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC

por Huber, Sandra, Baer, Constance, Hutter, Stephan, Dicker, Frank, Fuhrmann, Irene, Meggendorfer, Manja, Pohlkamp, Christian, Kern, Wolfgang, Haferlach, Torsten, Haferlach, Claudia, Hoermann, Gregor
Publicado 2023

Risk prediction in MDS: independent validation of the IPSS-M—ready for routine?

por Baer, Constance, Huber, Sandra, Hutter, Stephan, Meggendorfer, Manja, Nadarajah, Niroshan, Walter, Wencke, Platzbecker, Uwe, Götze, Katharina S., Kern, Wolfgang, Haferlach, Torsten, Hoermann, Gregor, Haferlach, Claudia
Publicado 2023